Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
The New Zealand Medical Journal|October 8, 2014
The changing landscape of antimicrobial resistance in New ZealandDeborah A Williamson, Helen HeffernanPathology|March 13, 2015
Contemporary genomic approaches in the diagnosis and typing of Staphylococcus aureusDeborah A Williamson, Helen Heffernan, Graeme NimmoThe New Zealand Medical Journal|April 28, 2017
The clear and present danger of carbapenemase-producing Enterobacteriaceae (CPE) in New Zealand: time for a national response planMatthew Blakiston, Helen Heffernan, Sally Roberts, et al.The New Zealand Medical Journal|June 22, 2018
Antimicrobial resistance among Shigella in New ZealandHelen Heffernan, Rosemary Woodhouse, Chris Hewison, et al.The Australian & New Zealand Journal of Obstetrics & Gynaecology|August 18, 2016
Neonatal invasive pneumococcal disease: New Zealand experience in the era of pneumococcal vaccinationVicki Mount, Cameron Burton, Catherine Jackson, et al.The New Zealand Medical Journal|March 25, 2017
Household transmission of NDM-producing E. coli in New ZealandMatthew Blakiston, Sally A Roberts, Joshua T Freeman, et al.The New Zealand Medical Journal|April 27, 2004
Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002Helen Heffernan, Mike Brokenshire, Rosemary Woodhouse, et al.The New Zealand Medical Journal|April 2, 2015
Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobialsDragana Drinkovic, Arthur J Morris, Kristin Dyet, et al.Emerging Infectious Diseases|March 23, 2023
Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004-2020Cameron Burton, Emma Best, Matthew Broom, et al.Journal of Global Antimicrobial Resistance|November 23, 2016
First cases of KPC-type carbapenemase-producing bacteria in patients in New Zealand hospitalsHelen Heffernan, Kristin Dyet, Sean Munroe, et al.Pageof 3